The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
DeepLPI: a novel deep learning-based model for protein-ligand interaction prediction for drug repurposing
Open accessPreprint — published as 10.1038/s41598-022-23014-1 · Paper page
Abstract
The substantial cost of new drug research and development has consistently posed a huge burden for both pharmaceutical companies and patients. In order to lower the expenditure and development failure rate, repurposing existing and approved drugs by identifying interactions between drug molecules and target proteins based on computational methods have gained growing attention. Here, we propose the DeepLPI, a novel deep learning-based model that mainly consists of ResNet-based 1-dimensional convolutional neural network (1D CNN) and bi-directional long short term memory network (biLSTM), to establish an end-to-end framework for protein-ligand interaction prediction. We first encode the raw drug molecular sequences and target protein sequences into dense vector representations, which go through two ResNet-based 1D CNN modules to derive features, respectively. The extracted feature vectors are concatenated and further fed into the biLSTM network, followed by the MLP module to finally predict protein-ligand interaction. We downloaded the well-known BindingDB and Davis dataset for training and testing our DeepLPI model. We also applied DeepLPI on a COVID-19 dataset for externally evaluating the prediction ability of DeepLPI. To benchmark our model, we compared our DeepLPI with the state-of-the-art methods of DeepCDA and DeepDTA, and observed that our DeepLPI outperformed these methods, suggesting the high accuracy of the DeepLPI towards protein-ligand interaction prediction. The high prediction performance of DeepLPI on the different datasets displayed its high capability of protein-ligand interaction in generalization, demonstrating that the DeepLPI has the potential to pinpoint new drug-target interactions and to find better destinations for proven drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Research works printed but not linked: 24
- 10.1038/nrd.2018.168 · DOI · Paper page
- 10.1001/jama.2020.1166 · DOI · Paper page
- 10.4103/0975-7406.72130 · DOI
- 10.1371/journal.ppat.1008341 · DOI
- 10.1016/j.drudis.2016.10.008 · DOI
- 10.3390/ijms22094435 · DOI · Paper page
- I. Wallach , M. Dzamba , and A. Heifets , “AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery.” arXiv preprint arXiv:1510.02855 (2015). · arXiv
- 10.3389/fgene.2020.607824 · DOI
- 10.1093/bioinformatics/btu626 · DOI · Paper page
- 10.1136/bmj.324.7344.1018 · DOI · Paper page
- 10.1093/bioinformatics/btq112 · DOI · Paper page
- 10.3390/molecules200610947 · DOI
- 10.1109/IJCNN.2016.7727339 · DOI
- 10.1093/bioinformatics/bty593 · DOI · Paper page
- 10.1093/bioinformatics/btaa544 · DOI · Paper page
- 10.1021/acs.jcim.7b00616 · DOI · Paper page
- 10.1016/j.cels.2021.05.017 · DOI · Paper page
- 10.1093/nar/gkl999 · DOI · Paper page
- 10.1038/nbt.1990 · DOI · Paper page
- Huang, K. et al, “Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development”, arXiv preprints, 2021. arXiv:2102.09548 · arXiv
- 10.1021/ci100050t · DOI · Paper page
- 10.1109/CVPR.2016.90 · DOI · Paper page
- 10.1109/ICCV.2015.123 · DOI · Paper page
- D. P. Kingma and J. Ba , “Adam: A Method for Stochastic Optimization,” arXiv preprint arXiv: 1412.6980 (2014). · arXiv
Metadata
- Authors
- Wei, B., Zhang, Y., & Gong, X.
- Affiliations
- Princeton University (US)
- University of Utah (US)
- Corresponding author
- Wei, Bomin
- Venue
- Scientific Reports
- Publisher
- openRxiv
- Published
- 2021-12-03
- Volume
- 12
- Issue
- 1
- Pages
- 18200-18200
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC9616420
- OpenAlex
- W4307479771
- Cited by
- 53
- References
- 1
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 18 · 2023: 8 · 2022: 1
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Scientific Reports (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- protein-ligand interaction prediction, drug repurposing, 1D convolutional neural network, bidirectional LSTM, ResNet, drug-target interactions, COVID-19 drug targets, BindingDB
- MeSH terms
- Deep Learning, COVID-19 Drug Treatment, Humans, Ligands, Neural Networks, Computer, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.